Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT05633927

Completed

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

HIV Infection | SARS-CoV-2 RNA Vaccines
NCT05116748

Completed

COVID19 Vaccine in SOT Adult Recipients (COVID19_VaxSOT)

COVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | Liver Transplant; Complications | Lung Transplant; Complications | Vaccine Response Impaired | Vaccination
NCT03989102

Completed

Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali

Malaria
NCT06266754

Enrolling by invitation

The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau

Vaccine Reaction
NCT05195008

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in Healthy Participants

Healthy Volunteer
NCT02385123

Terminated

Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers

Influenza | Influenza Immunisation
NCT04674189

Completed

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus
NCT03867162

Withdrawn

FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) (NDBR)

Tularemia
NCT05767138

Completed

STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

HPV-Related Cervical Carcinoma | HPV
NCT05144139

Completed

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

COVID-19 Pandemic
NCT05568693

Enrolling by invitation

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Corona Virus Disease 2019(COVID-19)
NCT05084976

Completed

Parental Perception of COVID-19 Vaccine in Technology Dependent Patients

Mechanical Ventilation Complication | Chronic Respiratory Failure | Tracheostomy Complication
NCT04553016

Active, not recruiting

A Study to Test Three Experimental HIV Vaccines in Healthy Adults. (HIV-CORE 006)

HIV-1-infection
NCT03753763

Completed

Safinamide for Multiple System Atrophy (MSA)

Multiple System Atrophy
NCT01347671

Completed

Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy

Pain | Diabetic Neuropathies
NCT01357837

Completed

Assessment of GRT6005 in Painful Osteoarthritis of the Knee

Osteoarthritis of the Knee
NCT03771963

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

Dengue Fever
NCT04537130

Unknown

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge (COVINVAC)

Covid19 | Pulmonary Fibrosis
NCT04442841

Unknown

HBV Vaccine in Anti-core Positive Donors After LT

Hepatitis B Reactivation
NCT04453488

Unknown

Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

Covid-19 | Sars-CoV2
NCT03042793

Completed

Vaccination With PD-L1 Peptide Against Multiple Myeloma

Multiple Myeloma
NCT02348320

Completed

Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
NCT00105053

Completed

Vaccine Treatment for Hormone Refractory Prostate Cancer

Prostate Cancer
NCT03811678

Completed

The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

Chronic Hepatitis c
NCT04311528

Unknown

9-valent HPV Vaccine in Postpartum Women

Human Papilloma Virus
NCT03819699

Terminated

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Alzheimer Disease
NCT03701438

Terminated

Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib

B-cell Malignancies
NCT01945424

Completed

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

Pregnancy | Influenza
NCT00584844

Completed

Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia
NCT00290355

Completed

Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

Lung Cancer, Non-Small Cell
NCT02590068

Terminated

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Hepatitis C
NCT02015091

Completed

Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults

Malaria
NCT02624375

Completed

Immune Response to Shingles Vaccination

Shingles
NCT02115958

Completed

The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine

Neoplasms, Lung
NCT03680417

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Safety Issues | Immunogenicity
NCT02438423

Completed

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Influenza
NCT00972517

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children

Influenza
NCT00968526

Completed

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza
NCT01159561

Completed

Western Equine Encephalitis Vaccine, Inactivated (WEE)

Virus
NCT02687373

Completed

Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya

Malaria
NCT01777308

Completed

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Infections, Meningococcal
NCT00661557

Completed

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

Infections, Meningococcal
NCT02876159

Completed

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination (FLU1)

Influenza
NCT03474055

Completed

Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India

Rotavirus Gastroenteritis
NCT00652743

Completed

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

Influenza
NCT02753413

Completed

Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women

Respiratory Syncytial Virus Infections
NCT03400488

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men

Coronary Artery Disease
NCT02661659

Withdrawn

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Malignant Pleural Mesothelioma (MPM)
NCT02983656

Completed

Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine

Varicocele
NCT02743117

Completed

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season (FluMist)

Healthy | Influenza

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations